BAC
Bank of America Corporation
BAC has a slight edge over PKBK overall, supported by stronger valuation and stronger modeled upside.
PKBK
Parke Bancorp, Inc.
PKBK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
PKBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
PKBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PKBK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over PKBK in the historical PE scenario, which offers more potential upside but is not a forecast.
PKBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.74 | -28% |
| Fair | 7.5x | $29.95 | -8.6% |
| Current | 8.3x | $32.76 | — |
| Expensive | 8.9x | $35.32 | +7.8% |
Historical ranges are pointers, not guarantees.
PKBK's PE is in its fair range at 8.3x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
PKBK Forward outlook
There aren't enough analyst estimates for PKBK to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
PKBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.97 | +40% |
| Q2 2026 | $3.84 | +49% |
| Q1 2026 | $3.50 | +45% |
| Q4 2025 | $3.16 | +39% |
| Q3 2025 | $2.84 | +21% |
| Q2 2025 | $2.57 | +43% |
| Q1 2025 | $2.41 | +24% |
| Q4 2024 | $2.27 | -3.4% |
PKBK earned $3.97 per share over the past year, up 40% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
PKBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24M | +14% |
| Q2 2026 | $23.9M | +28% |
| Q1 2026 | $23M | +32% |
| Q4 2025 | $22.7M | +36% |
| Q3 2025 | $21M | +34% |
| Q2 2025 | $18.7M | +20% |
| Q1 2025 | $17.4M | +15% |
| Q4 2024 | $16.8M | -1.4% |
PKBK's revenue has grown year over year for seven quarters in a row: $24M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 68% | +3.6 points |
| Q2 2026 | 68% | +9.2 points |
| Q1 2026 | 68% | +8.6 points |
| Q4 2025 | 64% | +6.2 points |
| Q3 2025 | 64% | +4 points |
| Q2 2025 | 59% | +2.3 points |
| Q1 2025 | 59% | +3.7 points |
| Q4 2024 | 58% | -7.6 points |
PKBK has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
PKBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13M | +16% |
| Q2 2026 | $5.9M | -12% |
| Q1 2026 | $13M | +96% |
| Q4 2025 | $14.4M | +70% |
| Q3 2025 | $11.2M | +20% |
| Q2 2025 | $6.7M | -24% |
| Q1 2025 | $6.6M | -21% |
| Q4 2022 | $9.1M | -0.4% |
PKBK's free cash flow was $46M over the past year, up 40% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PKBK.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over PKBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
PKBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +29.9K shares |
| 1 year | 0% | -5.8K shares |
| 3 years | -1.5% | -180K shares |
| 5 years | -1.4% | -173K shares |
| Available history | -0.5% | -58.8K shares |
PKBK has 12M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $6.5M |
| Q4 2024 | $2.2M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
PKBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.1x | Healthy |
PKBK has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
PKBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.6 | Neutral |
| Stochastic | 29.8 | Neutral |
PKBK's weekly RSI is 54 (neutral) and its Stochastic is 30 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
PKBK PE vs Financial Services Sector
| Metric | PKBK | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 37% below |
| PE % | 63 | 63 | Same percentile |
PKBK has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
PKBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.8 | 0.1% below |
| 20 week MA | $33.5 | 2.1% below |
| 50 week MA | $30.4 | 7.7% above |
| 100 week MA | $25.4 | 29% above |
| 200 week MA | $21.9 | 50% above |
PKBK has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
PKBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.9 | $15.4 | -33% |
| 2021 | $15.4 | $21.0 | +36% |
| 2022 | $21.0 | $20.6 | -2% |
| 2023 | $20.6 | $20.3 | -1.6% |
| 2024 | $20.3 | $20.7 | +2.1% |
| 2025 | $20.7 | $24.8 | +20% |
| 2026 YTD | $24.8 | $32.8 | +32% |
PKBK has the edge over BAC on returns for 2026, with the stronger performance.